Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 116 participants.
Also called NCT07323381
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 116 participants
- Registry
-
NCT07323381
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07323381. Randomized; no masking; primary purpose treatment. Start 2025-12-30 (anticipated); primary completion 2027-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM
- Acronym
- HABIT-GEMs
- Condition
- Diabetes Type 2
- Intervention (Drug)
- Henagliflozin Proline Tablets treatment
- Intervention (Drug)
- Metformin XR treatment
- Lead sponsor
- Bin Lu
- Collaborator
- Shanxi Provincial People's Hospital
- Collaborator
- Zhongnan Hospital
- Collaborator
- Second Affiliated Hospital of Soochow University
- Collaborator
- The Second Affiliated Hospital of Shandong First Medical University
- Collaborator
- Fifth Affiliated Hospital, Sun Yat-Sen University
Record details
- Record id
cardio:ct-nct07323381- Content hash
c5e63c11bfb3efeb151014cb193881bfb9de8904d952572154fbc111019e682b